Gadoxetic acid-enhanced MRI with MR cholangiography for the preoperative evaluation of bile duct cancer

Journal of Magnetic Resonance Imaging

Volumn 38, Issue 1, 2013, Pages 138-147

  Sun, Hye Young ^a   Lee, Jeong Min ^a   Park, Hee Sun ^b   Yoon, Jeong Hee ^a   Baek, Jee Hyun ^a   Han, Joon Koo ^a   Choi, Byung Ihn ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Konkuk University Hospital   (South Korea)

Author keywords

bile duct cancer; gadoxetic acid; MRI with MR cholangiography

Indexed keywords

GADOXETIC ACID;

ADULT; AGED; ARTICLE; BILE DUCT CANCER; CANCER STAGING; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HEALTH CARE; HUMAN; LYMPH NODE METASTASIS; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

BILE DUCT CANCER; GADOXETIC ACID; MRI WITH MR CHOLANGIOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; CHOLANGIOPANCREATOGRAPHY, MAGNETIC RESONANCE; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; MALE; MIDDLE AGED; MULTIMODAL IMAGING; OBSERVER VARIATION; PATIENT SELECTION; PREOPERATIVE CARE; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 84880128655     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.23957     Document Type: Article

References (40)

1. Anderson CD, Pinson CW, Berlin J, Chari RS,. Diagnosis and treatment of cholangiocarcinoma. Oncologist 2004; 9: 43-57.
2. Jarnagin WR, Fong Y, DeMatteo RP, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 2001; 234: 507-517; discussion 517-519.
3. Jarnagin W, Winston C,. Hilar cholangiocarcinoma: diagnosis and staging. HPB (Oxford) 2005; 7: 244-251.
4. Neuhaus P, Jonas S, Bechstein WO, et al. Extended resections for hilar cholangiocarcinoma. Ann Surg 1999; 230: 808-818; discussion 819.
5. Park MS, Lee DK, Kim MJ, et al. Preoperative staging accuracy of multidetector row computed tomography for extrahepatic bile duct carcinoma. J Comput Assist Tomogr 2006; 30: 362-367.
6. Zech CJ, Schoenberg SO, Reiser M, Helmberger T,. Cross-sectional imaging of biliary tumors: current clinical status and future developments. Eur Radiol 2004; 14: 1174-1187.
7. Choi JY, Kim MJ, Lee JM, et al. Hilar cholangiocarcinoma: role of preoperative imaging with sonography, MDCT, MRI, and direct cholangiography. AJR Am J Roentgenol 2008; 191: 1448-1457.
8. Cho ES, Park MS, Yu JS, Kim MJ, Kim KW,. Biliary ductal involvement of hilar cholangiocarcinoma: multidetector computed tomography versus magnetic resonance cholangiography. J Comput Assist Tomogr 2007; 31: 72-78.
9. Lee HY, Kim SH, Lee JM, et al. Preoperative assessment of resectability of hepatic hilar cholangiocarcinoma: combined CT and cholangiography with revised criteria. Radiology 2006; 239: 113-121.
10. Masselli G, Gualdi G,. Hilar cholangiocarcinoma: MRI/MRCP in staging and treatment planning. Abdom Imaging 2008; 33: 444-451.
11. Masselli G, Manfredi R, Vecchioli A, Gualdi G,. MR imaging and MR cholangiopancreatography in the preoperative evaluation of hilar cholangiocarcinoma: correlation with surgical and pathologic findings. Eur Radiol 2008; 18: 2213-2221.
12. Masui T, Katayama M, Kobayashi S, et al. Magnetic resonance cholangiopancreatography: comparison of respiratory-triggered three-dimensional fast-recovery fast spin-echo with parallel imaging technique and breath-hold half-Fourier two-dimensional single-shot fast spin-echo technique. Radiat Med 2006; 24: 202-209.
13. Keogan MT, Edelman RR,. Technologic advances in abdominal MR imaging. Radiology 2001; 220: 310-320.
14. Sodickson A, Mortele KJ, Barish MA, Zou KH, Thibodeau S, Tempany CM,. Three-dimensional fast-recovery fast spin-echo MRCP: comparison with two-dimensional single-shot fast spin-echo techniques. Radiology 2006; 238: 549-559.
15. Lee VS, Lavelle MT, Rofsky NM, et al. Hepatic MR imaging with a dynamic contrast-enhanced isotropic volumetric interpolated breath-hold examination: feasibility, reproducibility, and technical quality. Radiology 2000; 215: 365-372.
16. Kim MJ, Mitchell DG, Ito K, Kim PN,. Hepatic MR imaging: comparison of 2D and 3D gradient echo techniques. Abdom Imaging 2001; 26: 269-276.
17. Yin LL, Song B, Xu J, Li YC,. Hilar cholangiocarcinoma: preoperative evaluation with a three dimensional volumetric interpolated breath-hold examination magnetic resonance imaging sequence. Chin Med J (Engl) 2007; 120: 636-642.
18. Ryoo I, Lee JM, Chung YE, et al. Gadobutrol-enhanced, three-dimensional, dynamic MR imaging with MR cholangiography for the preoperative evaluation of bile duct cancer. Invest Radiol 2010; 45: 217-224.
19. Kim MJ, Mitchell DG, Ito K, Outwater EK,. Biliary dilatation: differentiation of benign from malignant causes-value of adding conventional MR imaging to MR cholangiopancreatography. Radiology 2000; 214: 173-181.
20. Hanninen EL, Pech M, Jonas S, et al. Magnetic resonance imaging including magnetic resonance cholangiopancreatography for tumor localization and therapy planning in malignant hilar obstructions. Acta Radiol 2005; 46: 462-470.
21. Lee JM, Zech CJ, Bolondi L, et al. Consensus report of the 4th international forum for gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid magnetic resonance imaging. Korean J Radiol 2011; 12: 403-415.
22. Schuhmann-Giampieri G, Schmitt-Willich H, Press WR, Negishi C, Weinmann HJ, Speck U,. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology 1992; 183: 59-64.
23. Takao H, Akai H, Tajima T, et al. MR imaging of the biliary tract with Gd-EOB-DTPA: effect of liver function on signal intensity. Eur J Radiol 2011; 77: 325-329.
24. Lee NK, Kim S, Lee JW, et al. Biliary MR imaging with Gd-EOB-DTPA and its clinical applications. Radiographics 2009; 29: 1707-1724.
25. Motosugi U, Ichikawa T, Morisaka H, et al. Detection of pancreatic carcinoma and liver metastases with gadoxetic acid-enhanced MR imaging: comparison with contrast-enhanced multi-detector row CT. Radiology 2011; 260: 446-453.
26. Lee MW, Lee JM, Lee JY, et al. Preoperative evaluation of the hepatic vascular anatomy in living liver donors: comparison of CT angiography and MR angiography. J Magn Reson Imaging 2006; 24: 1081-1087.
27. Kim HJ, Lee JM, Kim SH, et al. Evaluation of the longitudinal tumor extent of bile duct cancer: value of adding gadolinium-enhanced dynamic imaging to unenhanced images and magnetic resonance cholangiography. J Comput Assist Tomogr 2007; 31: 469-474.
28. Choi SH, Han JK, Lee JM, et al. Differentiating malignant from benign common bile duct stricture with multiphasic helical CT. Radiology 2005; 236: 178-183.
29. Lu DS, Reber HA, Krasny RM, Kadell BM, Sayre J,. Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT. AJR Am J Roentgenol 1997; 168: 1439-1443.
30. Kim JK, Kim KA, Park BW, Kim N, Cho KS,. Feasibility of diffusion-weighted imaging in the differentiation of metastatic from nonmetastatic lymph nodes: early experience. J Magn Reson Imaging 2008; 28: 714-719.
31. Park HS, Lee JM, Choi JY, et al. Preoperative evaluation of bile duct cancer: MRI combined with MR cholangiopancreatography versus MDCT with direct cholangiography. AJR Am J Roentgenol 2008; 190: 396-405.
32. Tschirch FT, Struwe A, Petrowsky H, Kakales I, Marincek B, Weishaupt D,. Contrast-enhanced MR cholangiography with Gd-EOB-DTPA in patients with liver cirrhosis: visualization of the biliary ducts in comparison with patients with normal liver parenchyma. Eur Radiol 2008; 18: 1577-1586.
33. Kitao A, Zen Y, Matsui O, et al. Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging-correlation with molecular transporters and histopathologic features. Radiology 2010; 256: 817-826.
34. Roche CJ, Hughes ML, Garvey CJ, et al. CT and pathologic assessment of prospective nodal staging in patients with ductal adenocarcinoma of the head of the pancreas. AJR Am J Roentgenol 2003; 180: 475-480.
35. Akduman EI, Momtahen AJ, Balci NC, Mahajann N, Havlioglu N, Wolverson MK,. Comparison between malignant and benign abdominal lymph nodes on diffusion-weighted imaging. Acad Radiol 2008; 15: 641-646.
36. Lin G, Ho KC, Wang JJ, et al. Detection of lymph node metastasis in cervical and uterine cancers by diffusion-weighted magnetic resonance imaging at 3T. J Magn Reson Imaging 2008; 28: 128-135.
37. Sumi M, Van Cauteren M, Nakamura T,. MR microimaging of benign and malignant nodes in the neck. AJR Am J Roentgenol 2006; 186: 749-757.
38. Holzapfel K, Duetsch S, Fauser C, Eiber M, Rummeny EJ, Gaa J,. Value of diffusion-weighted MR imaging in the differentiation between benign and malignant cervical lymph nodes. Eur J Radiol 2009; 72: 381-387.
39. Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann HJ,. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol 2005; 40: 715-724.
40. Zech CJ, Vos B, Nordell A, et al. Vascular enhancement in early dynamic liver MR imaging in an animal model: comparison of two injection regimen and two different doses Gd-EOB-DTPA (gadoxetic acid) with standard Gd-DTPA. Invest Radiol 2009; 44: 305-310.